Drug Type Small molecule drug |
Synonyms C 17, C17 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC14H13ClN4OS2 |
InChIKeyGVFQMXWECALIKN-UHFFFAOYSA-N |
CAS Registry333746-75-1 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Sarcoglycanopathies | Preclinical | Italy | 01 Oct 2024 |





